Device / Technology News

RSS

'Open Access - Open Data' Conference to take place December 13 - 14, 2010 in Cologne

From December 13 - 14, 2010, the "Open Access - Open Data" Conference will be taking place in Cologne. It is an international expert conference that will look closely on how the Open Access movement has developed within the last five years and what is going to happen within the next five to ten years. Additionally, the "Open Data Movement" that is gaining more and more importance will be under consideration.

10 Aug 2010

Olympus America introduces new V-System for ERCP procedure

Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.

From Evident Corporation - Life Sciences 10 Aug 2010

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.

10 Aug 2010

CareView files patent for innovative technology to prevent decubitus ulcers

CareView Communications, Inc. ("CareView" or the "Company"), an information technology provider to the healthcare industry, announced that it has filed a new patent with the United States Patent and Trademark Office to cover an innovative technology that will assist hospitals and other medical facilities in their efforts to prevent decubitus ulcers or "bed sores" experienced by patients. CareView's new product covered by the pending patent uses the CareView System monitoring system to ensure timely patient movement which assists caregivers in the prevention and treatment of bed sores.

10 Aug 2010

Computerized warning system alerts harmful drug orders for older hospital patients

Adverse drug events, such as dizziness or confusion occur in an estimated 40 percent of all hospital patients and can be the result of inappropriate medications being ordered. Not surprisingly, elderly individuals are particularly vulnerable to these adverse events, which not only result in longer hospitalizations, but can also pose a threat of serious complications and even death.

10 Aug 2010

Brain-wave pattern study may lead to techniques for enhancing sleep spindles

People who have trouble sleeping in noisy environments often resort to strategies like earplugs or noise-cancelling headphones that muffle the sound, but a new study from investigators at Massachusetts General Hospital (MGH) may lead to ways to block disturbing sounds within the brain. In their report in the August 10 issue of Current Biology, the team reports finding a brain-wave pattern, reflecting activity of a key structure, that predicts the ease at which sleep can be disrupted by noise.

10 Aug 2010

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that a scientific paper co-authored by Ryo Kubota, M.D., Ph.D., chairman, president and chief executive officer of Acucela, has been published in Experimental Eye Research. The paper, "Visual Cycle Modulation in Neurovascular Retinopathy" was also co-authored by scientists from Children's Hospital and Harvard Medical School in Boston and demonstrates for the first time the impact of treatment with a visual cycle modulator (VCM) on retinopathy in an immature eye.

10 Aug 2010

Scientists develop life long hip joint replacement device

Total knee and hip joint replacement devices that last a lifetime are closer to reality thanks to recent breakthroughs in Department of Physics laboratories at the University of Alabama at Birmingham involving specialized nanodiamonds a billionth of a meter in size.

10 Aug 2010

Cegedim Dendrite, TAKE Solutions form strategic partnership

As part of the Cegedim Dendrite Alliance Program, created to expand its open business model through alliances with leading technology, software and consulting companies, Cegedim Dendrite today announced its partnership in India with TAKE Solutions Ltd.

10 Aug 2010

Social media can complicate but also improve hospital care

The Los Angeles Times: "Hospital officials in California and elsewhere have faced an uneasy relationship with Facebook and other forms of social networking. Managers, struggling to prevent staffers from posting patient information on the sites, have developed no-tolerance policies and blocked employees from using Facebook and similar websites at work.

10 Aug 2010

New microchip technology to detect oral cancer

A new test for oral cancer, which a dentist could perform by simply using a brush to collect cells from a patient's mouth, is set to be developed by researchers at the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust.

10 Aug 2010

Study to evaluate sensitivity of mammography combined with somo•v ABUS technology in breast cancer screening

Henry Ford West Bloomfield Hospital announced today that it has joined U-Systems national clinical research study designed to evaluate whether digital mammography, when combined with the somo•v Automated Breast Ultrasound System (ABUS) from U-Systems, Inc (Sunnyvale, CA), is more sensitive in detecting breast lesions compared to mammography alone in women with dense breasts. Henry Ford West Bloomfield Hospital is the only site in Michigan, and one of only ten breast cancer centers in the entire country, currently recruiting women for the SOMO•INSIGHT clinical study.

10 Aug 2010

Duke University physicists develop technique to inject material into cells through sharp fluid jets

Duke University physicists have developed a way to produce sharp fluid jets with enough precision that they can inject material into a single, living cell. The technique promises a way to deliver drugs to cells one at a time, which is likely to be very valuable for research involving stem cells and other cellular-level studies. The research appears in the current issue of the APS journal Physical Review Letters.

10 Aug 2010

Ikaria announces voluntary recall of INOMAX DS drug-delivery system in US and Canada

Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.

10 Aug 2010

Vena cava blood clot filters may cause potential life-threatening complications: Study

Two specific types of vena cava filters, devices used to prevent blood clots from reaching the lungs, appear to have evidence of fracturing inside the body, with some fractured fragments traveling to the heart and causing potentially life-threatening complications, according to a report posted online today that will appear in the November 8 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Aug 2010

DOJ likely to intervene in St. Jude heart device kickback lawsuit

The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.

10 Aug 2010

Lentigen receives NIH SBIR grant for program on clinical vector for TCR immunotherapy targeted to melanoma

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).

9 Aug 2010

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.

9 Aug 2010

Aptus reports successful treatment with EndoStapling System in Europe

Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.

9 Aug 2010

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today the company received CE Mark for AdVance XP. The device is the latest generation of AMS' AdVance sling, a minimally invasive implant for the treatment of male stress urinary incontinence (SUI).

9 Aug 2010

Device / Technology News

'Open Access - Open Data' Conference to take place December 13 - 14, 2010 in Cologne

Olympus America introduces new V-System for ERCP procedure

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

CareView files patent for innovative technology to prevent decubitus ulcers

Computerized warning system alerts harmful drug orders for older hospital patients

Brain-wave pattern study may lead to techniques for enhancing sleep spindles

Scientific paper explains impact of visual cycle modulation in neurovascular retinopathy

Scientists develop life long hip joint replacement device

Cegedim Dendrite, TAKE Solutions form strategic partnership

Social media can complicate but also improve hospital care

New microchip technology to detect oral cancer

Study to evaluate sensitivity of mammography combined with somo•v ABUS technology in breast cancer screening

Duke University physicists develop technique to inject material into cells through sharp fluid jets

Ikaria announces voluntary recall of INOMAX DS drug-delivery system in US and Canada

Vena cava blood clot filters may cause potential life-threatening complications: Study

DOJ likely to intervene in St. Jude heart device kickback lawsuit

Lentigen receives NIH SBIR grant for program on clinical vector for TCR immunotherapy targeted to melanoma

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Aptus reports successful treatment with EndoStapling System in Europe

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News